Viridian Therapeutics, Inc.\DE Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Viridian Therapeutics, Inc.\DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Viridian Therapeutics, Inc.\DE for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.54 | 2,258 | 30,580 | 484,273 | 486.5 K to 484.3 K (-0.46 %) |
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.79 | 1,500 | 20,687 | 486,531 | 488 K to 486.5 K (-0.31 %) |
| Feb 28 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.04 | 6,500 | 91,252 | 488,031 | 494.5 K to 488 K (-1.31 %) |
| Feb 24 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 13.65 | 1,800 | 24,566 | 494,531 | 496.3 K to 494.5 K (-0.36 %) |
| Feb 24 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEFKOFF KYLE | Director | Sell | S | 14.36 | 4,102 | 58,886 | 496,331 | 500.4 K to 496.3 K (-0.82 %) |
| Feb 16 2017 | SGNL | MIRAGEN THERAPEUTI ... | Leverone Jason A. | CFO, Treasurer & Se ... | Option Exercise | A | 11.01 | 77,500 | 853,275 | 77,500 | |
| Feb 16 2017 | SGNL | MIRAGEN THERAPEUTI ... | RUBIN PAUL D | EVP, Research & Dev ... | Option Exercise | A | 11.01 | 87,500 | 963,375 | 87,500 | |
| Feb 16 2017 | SGNL | MIRAGEN THERAPEUTI ... | Levy Adam Scott | Chief Business Offi ... | Option Exercise | A | 11.01 | 87,500 | 963,375 | 87,500 | |
| Feb 16 2017 | SGNL | MIRAGEN THERAPEUTI ... | Marshall William Stuart | President & CEO | Option Exercise | A | 11.01 | 200,000 | 2,202,000 | 200,000 | |
| Feb 13 2017 | SGNL | MIRAGEN THERAPEUTI ... | LEBOW BENNETT S | Director | Buy | M | 5.39 | 279,067 | 1,504,171 | 280,600 | 1.5 K to 280.6 K (+18,203.98 %) |
| Feb 08 2017 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Option Exercise | M | 7.65 | 1,200 | 9,180 | 0 | |
| Feb 08 2017 | SGNL | SIGNAL GENETICS, I ... | Gonyer David A | Director | Buy | M | 7.65 | 1,200 | 9,180 | 1,899 | 699 to 1.9 K (+171.67 %) |
| Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | LEBOW BENNETT S | Director | Option Exercise | M | 7.65 | 1,200 | 9,180 | 0 | |
| Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | LEBOW BENNETT S | Director | Buy | M | 7.65 | 1,200 | 9,180 | 1,533 | 333 to 1.5 K (+360.36 %) |
| Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Option Exercise | M | 7.65 | 1,200 | 9,180 | 0 | |
| Feb 07 2017 | SGNL | SIGNAL GENETICS, I ... | Smith Robin L | Director | Buy | M | 7.65 | 1,200 | 9,180 | 1,900 | 700 to 1.9 K (+171.43 %) |